Differences in clinical characteristics and prognosis of Penicilliosis among HIV-negative patients with or without underlying disease in Southern China: a retrospective study

Table 5 Treatment outcomes among HIV-negative patients with and without underlying disease

Variables	Group D (N = 18)	Group ND (N = 25)	P-values
Treatment received	14	23	0.378
Deterioration (discontinue treatment)	4	2
Medication
-Amphotericin B then itraconazole	5	6	1.000
-Itraconazole	4	2	0.378
-Fluconazole then itraconazole	4	10	0.220
-Voriconazole	1	5	0.367
Outcome, n (%)			0.022*
-Cure	5 (27.78)	13 (52 %)
-Recovery	6 (33.33 %)	7 (28 %)
-Dead	8 (44.44 %)	3 (12 %)

Patients with Penicillium marneffei infection were divided into two groups; Group D included patients with underlying disease, and Group ND included patients without underlying disease
*P < 0.05
Data are presented as the number of patients, unless otherwise indicated